FGF21 has been considered a promising intervention target for metabolic diseases, including fatty liver, obesity, and diabetes due to its insulin-sensitizing and thermogenesis-inducing effects [18]. Here, FGF21 is linked to obesity due to melanocortin 4 receptor deficiency.